Furthermore, we show that humans with the coronary artery disease (CAD) risk variant of TRIB3 (rs2295490-G) demonstrate increased TRIB3 expression and decreased macrophage efferocytosis efficiency. This evidence concerns the gene TRIB3 and coronary artery disorder.